Impact of an alternative steroid on the relative bioavailability and bioequivalence of a novel versus the originator formulation of abiraterone acetate
- DOI
- 10.1007/s00280-017-3360-3
- Published
- 2017-07-10
- Container
- Cancer Chemotherapy and Pharmacology
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s00280-017-3360-3,
title = {Impact of an alternative steroid on the relative bioavailability and bioequivalence of a novel versus the originator formulation of abiraterone acetate},
author = {Azra Hussaini and Anthony J. Olszanski and Cy A. Stein and Bill Bosch and Paul Nemeth},
year = {2017},
journal = {Cancer Chemotherapy and Pharmacology},
doi = {10.1007/s00280-017-3360-3},
url = {https://doi.org/10.1007/s00280-017-3360-3}
}RIS
TY - JOUR TI - Impact of an alternative steroid on the relative bioavailability and bioequivalence of a novel versus the originator formulation of abiraterone acetate AU - Azra Hussaini AU - Anthony J. Olszanski AU - Cy A. Stein AU - Bill Bosch AU - Paul Nemeth PY - 2017 JO - Cancer Chemotherapy and Pharmacology DO - 10.1007/s00280-017-3360-3 UR - https://doi.org/10.1007/s00280-017-3360-3 ER -
APA
Hussaini, A., Olszanski, A. J., Stein, C. A., Bosch, B., & Nemeth, P. (2017). Impact of an alternative steroid on the relative bioavailability and bioequivalence of a novel versus the originator formulation of abiraterone acetate. Cancer Chemotherapy and Pharmacology. https://doi.org/10.1007/s00280-017-3360-3
Source records
- crossref · retrieved 2026-09-25T12:19:23.606Z